Ascend Wellness Holdings (AAWH) Change in Receivables (2020 - 2026)

Ascend Wellness Holdings' (AAWH) quarterly Change in Receivables came in at -$601000.0 in Q1 2026, down 437.64% year-on-year from $178000.0 in Q1 2025, and up 67.01% quarter-over-quarter from -$1.8 million in Q4 2025.

Ascend Wellness Holdings (AAWH) Change in Receivables (2020 - 2026) Analysis & Trends

Ascend Wellness Holdings' Change in Receivables history runs 7 years deep, the most recent figure standing at -$601000.0 for Q1 2026.

  • On a quarterly basis, Change in Receivables fell 437.64% year-over-year to -$601000.0 in Q1 2026; TTM through Mar 2026 was -$8.7 million, a 1158.27% decrease from a year earlier, with the FY2025 full-year figure at -$7.9 million, down 196.07% from the prior year.
  • Change in Receivables advanced to -$601000.0 in Q1 2026 per AAWH's latest filing, from -$1.8 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $7.6 million in Q1 2024 and bottomed at -$6.1 million in Q2 2025.
  • The 5-year median for Change in Receivables is $714000.0 (2022), against an average of $1.2 million.
  • Across the five-year window, Change in Receivables jumped 320.5% in 2023 and tumbled 940.17% in 2025, its largest moves.
  • Year by year, Change in Receivables stood at $714000.0 in 2022, then jumped by 308.82% to $2.9 million in 2023, then tumbled by 176.5% to -$2.2 million in 2024, then increased by 18.41% to -$1.8 million in 2025, then soared by 67.01% to -$601000.0 in 2026.
  • Per Business Quant, the three latest AAWH Change in Receivables figures stand at -$601000.0 (Q1 2026), -$1.8 million (Q4 2025), and -$191000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -78.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 106.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -621.82 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -38.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 126.30 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 81.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Ascend Wellness Holdings 83.00 Mn 22.91 Mn 44.88 Mn -601,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -601,000.00
Mar 31, 2026 -601,000.00
Dec 31, 2025 -1.82 Mn
Dec 31, 2025 -1.82 Mn
Sep 30, 2025 -191,000.00
Sep 30, 2025 -191,000.00
Jun 30, 2025 -6.09 Mn
Jun 30, 2025 -6.09 Mn
Mar 31, 2025 178,000.00
Mar 31, 2025 178,000.00
Dec 31, 2024 -2.23 Mn
Dec 31, 2024 -2.23 Mn
Sep 30, 2024 3.46 Mn
Sep 30, 2024 3.46 Mn
Jun 30, 2024 -585,000.00
Jun 30, 2024 -585,000.00
Mar 31, 2024 7.60 Mn
Mar 31, 2024 7.60 Mn
Dec 31, 2023 2.92 Mn
Dec 31, 2023 2.92 Mn